Clinical Trials · NCT07407348
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 80
- Start date
- Mar 2026
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the concentration-time curve of survodutide in plasma at steady state over a uniform dosing interval tau (AUC tau,ss)